SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-091434
Filing Date
2023-08-14
Accepted
2023-08-14 16:40:44
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 tm2323738d1_424b3.htm 424B3 267548
2 GRAPHIC tm2314775d1_posamimg001.jpg GRAPHIC 25917
3 GRAPHIC tm2314775d1_posamimg002.jpg GRAPHIC 21296
4 GRAPHIC tm2314775d1_posamimg003.jpg GRAPHIC 34101
  Complete submission text file 0001104659-23-091434.txt   380993
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267328 | Film No.: 231171317
SIC: 2834 Pharmaceutical Preparations